EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review

Hesham M Abdalla, Ahmed K Mahmoud iD, Ahmed E Khedr, Juan M Farina iD, Isabel G Scalia iD, Mohammed Tiseer Abbas iD, Kamal A Awad, Nima Baba Ali iD, Nadera N Bismee, Sogol Attaripour Esfahani, Niloofar Javadi, Milagros Pereyra iD und 4 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252011029 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hesham M Abdalla und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Mayo Clinic, Phoenix, AZ 85054, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Lipoprotein(a). Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipoprotein (a) is a complex lipid molecule that has sparked immense interest in recent years, after studies demonstrated its significant association with several cardiovascular conditions. Lp(a) promotes cardiovascular disease through its combined proatherogenic, pro-inflammatory, and prothrombotic effects. While the measurement of Lp(a) has become widely available, effective methods to reduce its concentration are currently limited. However, emerging data from ongoing clinical trials involving antisense oligonucleotides have indicated promising outcomes in effectively reducing Lp(a) concentrations. This may serve as a potential therapeutic target in the management and prevention of myocardial infarction, calcific aortic stenosis, and cerebrovascular accidents. In contrast, the role of Lp(a) in atrial fibrillation, in-stent restenosis, cardiac allograft vasculopathy, and bioprosthetic aortic valve degeneration remains unclear. This review article aims to thoroughly review the existing literature and provide an updated overview of the evidence surrounding the association of Lp(a) and these cardiovascular diseases. We seek to highlight controversies in the existing literature and offer directions for future investigations to better understand Lp(a)’s precise role in these conditions, while providing a summary of its unique molecular characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesLipoprotein(a)AnimalsHumansAortic Valve StenosisAtrial FibrillationHeart Disease Risk FactorsRisk Factors

Stichwörter der Autor:innen

atrial fibrillationbioprosethetic aortic valve degenerationcardiac allograft vasculopathyin-stent restenosislipoprotein(a)

Substanzen

Lipoprotein(a)LPA protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Department of Cardiothoracic Surgery, Mayo Clinic, Phoenix, AZ 85054, USA.

ORCID-Profile: Ahmed K Mahmoud, Juan M Farina, Isabel G Scalia, Mohammed Tiseer Abbas, Nima Baba Ali, Milagros Pereyra, Said Alsidawi, Reza Arsanjani

Zitieren

APA

Abdalla, H. M., Mahmoud, A. K., Khedr, A. E., Farina, J. M., Scalia, I. G., Abbas, M. T., Awad, K. A., Baba Ali, N., Bismee, N. N., Attaripour Esfahani, S., Javadi, N., Pereyra, M., Alsidawi, S., Lester, S. J., Ayoub, C., & Arsanjani, R. (2024). Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011029

Vancouver

Abdalla HM, Mahmoud AK, Khedr AE, Farina JM, Scalia IG, Abbas MT, et al. Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011029

BibTeX
@article{Abdalla2024,
  author = {Abdalla, Hesham M and Mahmoud, Ahmed K and Khedr, Ahmed E and Farina, Juan M and Scalia, Isabel G and Abbas, Mohammed Tiseer and Awad, Kamal A and Baba Ali, Nima and Bismee, Nadera N and Attaripour Esfahani, Sogol and Javadi, Niloofar and Pereyra, Milagros and Alsidawi, Said and Lester, Steven J and Ayoub, Chadi and Arsanjani, Reza},
  title = {Lipoprotein (a) as a Cardiovascular Risk Factor in Controversial Clinical Scenarios: A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252011029}
}
Kostenlos starten →